Delivery Order SPE2DB20D1109-SPE2DB23FQ02V
Award Date
9/28/23
Potential Completion Date
9/29/23
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $19,624.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE medical supplies. The contract has a firm fixed price and is a delivery order with an ultimate completion date of August 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,908.55 firm fixed-price contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE medication, with a completion date of June 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,833.70 firm-fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE/ML, a vaccine product. The award has an ultimate completion date of June 26, 2023 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $2,927.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML medical supplies, with an ultimate completion date of November 20, 2023. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of HAVRIX 1,440 units/mL syringes, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $3,247.20 firm fixed-price delivery order falls under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to supply a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,769.15 firm fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, which are likely vaccines or other medical supplies. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide HAVRIX 1,440 UNIT/ML SYRINGEML. The $1,833.70 firm fixed-price delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,842.30 for the supply of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, on May 16, 2022, with a completion date of May 17, 2022. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999...
This federal contract award, valued at $1,697.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of 1,440 unit/mL syringes of the HAVRIX vaccine. This is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
This federal contract award, valued at $1,833.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product. The award is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of August 14, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...